Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination.

ABSTRACT: Our understanding of cellular immunity in response to COVID-19 infection or vaccination is limited because of less commonly used techniques. We investigated both the cellular and humoral immune responses before and after the administration of a third dose of the SARS-CoV-2 vaccine among a group of healthcare workers. Cellular immunity was evaluated using the VIDAS interferon-gamma (IFNγ) RUO test, which enables automated measurement of IFNγ levels after stimulating peripheral blood lymphocytes. Booster doses significantly enhanced both cellular and humoral immunity. Concerning cellular response, the booster dose increased the percentage of positive IFNγ release assay (IGRA) results but no difference in IFNγ release was found. The cellular response was not associated with protection against

SUBMITTER: Montmaneix-Engels F 

PROVIDER: S-EPMC11004869 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature